A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Angiodynamics Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 3,100 shares of ANGO stock, worth $22,165. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,100
Previous 3,300 6.06%
Holding current value
$22,165
Previous $19,000 5.26%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.65 - $7.03 $3.92 Million - $4.88 Million
-693,852 Reduced 81.49%
157,651 $953,000
Q1 2024

May 15, 2024

SELL
$5.27 - $8.03 $855,178 - $1.3 Million
-162,273 Reduced 16.01%
851,503 $5 Million
Q4 2023

Feb 14, 2024

BUY
$6.17 - $8.04 $22,082 - $28,775
3,579 Added 0.35%
1,013,776 $7.95 Million
Q3 2023

Nov 14, 2023

BUY
$7.02 - $10.32 $3.31 Million - $4.86 Million
470,975 Added 87.34%
1,010,197 $7.38 Million
Q2 2023

Aug 14, 2023

BUY
$8.29 - $11.16 $975,368 - $1.31 Million
117,656 Added 27.91%
539,222 $5.62 Million
Q1 2023

May 15, 2023

BUY
$9.1 - $15.48 $53,753 - $91,440
5,907 Added 1.42%
421,566 $4.36 Million
Q4 2022

Feb 14, 2023

BUY
$12.06 - $21.55 $2.85 Million - $5.09 Million
236,301 Added 131.75%
415,659 $5.72 Million
Q3 2022

Nov 14, 2022

SELL
$19.54 - $24.3 $1.69 Million - $2.1 Million
-86,524 Reduced 32.54%
179,358 $3.67 Million
Q2 2022

Aug 15, 2022

BUY
$17.83 - $24.49 $836,886 - $1.15 Million
46,937 Added 21.44%
265,882 $5.15 Million
Q1 2022

May 16, 2022

BUY
$20.46 - $29.16 $4.12 Million - $5.87 Million
201,220 Added 1135.23%
218,945 $4.72 Million
Q4 2021

Feb 14, 2022

SELL
$24.35 - $30.97 $491,042 - $624,541
-20,166 Reduced 53.22%
17,725 $488,000
Q3 2021

Nov 15, 2021

SELL
$23.36 - $29.2 $718,390 - $897,987
-30,753 Reduced 44.8%
37,891 $983,000
Q2 2021

Aug 16, 2021

SELL
$22.39 - $28.07 $609,321 - $763,896
-27,214 Reduced 28.39%
68,644 $1.86 Million
Q1 2021

May 17, 2021

BUY
$15.44 - $23.4 $51,893 - $78,647
3,361 Added 3.63%
95,858 $2.24 Million
Q4 2020

Feb 16, 2021

BUY
$10.34 - $15.33 $31,195 - $46,250
3,017 Added 3.37%
92,497 $1.42 Million
Q3 2020

Nov 16, 2020

BUY
$8.26 - $12.74 $739,104 - $1.14 Million
89,480 New
89,480 $1.08 Million
Q4 2019

Feb 14, 2020

SELL
$14.23 - $18.16 $896,902 - $1.14 Million
-63,029 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$17.78 - $21.89 $228,686 - $281,549
12,862 Added 25.64%
63,029 $1.16 Million
Q2 2019

Aug 14, 2019

BUY
$18.78 - $25.01 $49,410 - $65,801
2,631 Added 5.53%
50,167 $988,000
Q1 2019

May 15, 2019

SELL
$19.43 - $23.46 $1.86 Million - $2.25 Million
-95,959 Reduced 66.87%
47,536 $0
Q4 2018

Feb 14, 2019

BUY
$18.9 - $22.06 $214,798 - $250,711
11,365 Added 8.6%
143,495 $2.89 Million
Q3 2018

Nov 13, 2018

SELL
$18.95 - $24.23 $666,168 - $851,781
-35,154 Reduced 21.01%
132,130 $0
Q2 2018

Aug 10, 2018

BUY
$17.42 - $23.0 $478,353 - $631,580
27,460 Added 19.64%
167,284 $0
Q1 2018

May 11, 2018

BUY
$15.71 - $17.7 $307,177 - $346,088
19,553 Added 16.26%
139,824 $2.41 Million
Q4 2017

Feb 09, 2018

BUY
$16.56 - $17.8 $530,483 - $570,205
32,034 Added 36.3%
120,271 $2 Million
Q3 2017

Nov 09, 2017

BUY
$16.09 - $18.76 $1.42 Million - $1.66 Million
88,237
88,237 $1.51 Million

Others Institutions Holding ANGO

About ANGIODYNAMICS INC


  • Ticker ANGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 39,107,800
  • Market Cap $280M
  • Description
  • AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...
More about ANGO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.